Concerto Biosciences Announces Strategic Business Development Hire
Concerto Biosciences, a biotechnology company designing microbial communities that restore health to our bodies and our environment, announced today that it has appointed Didier Vingadassalom, Ph.D., MBA, as Senior Director, Business Development.
- Concerto Biosciences, a biotechnology company designing microbial communities that restore health to our bodies and our environment, announced today that it has appointed Didier Vingadassalom, Ph.D., MBA, as Senior Director, Business Development.
- He will be responsible for maturing the team’s business development infrastructure, evaluating co-discovery and co-development partnership opportunities, and helping prioritize internal technology development directions from a business development perspective.
- “Didier has both a deep scientific background and years of business development experience— a potent combination and a perfect match for Concerto as our first senior director of business development,” said Cheri Ackerman, CEO of Concerto.
- “Our science team already excels at rapidly discovering optimized microbial products with our kChip platform, and Didier will help us point that unique capability at pressing, high-value opportunities in collaboration with our partners.”
Prior to joining Concerto Biosciences, Vingadassalom was senior director, business development and head of alliance management, SQZ Biotechnologies.